iDox.ai Announces Launch of iDox.ai Privacy Scout: AI-Powered Solution That Goes Beyond DLP to Protect Sensitive Data in Real Time
BoldSign® by Syncfusion® Earns 2025 SaaS Awards Finalist Honors and Five G2 Summer Badges
Layton Construction and TrueLook Partner to Deliver Complete Construction Site Visibility for Utah Mammoth’s New Practice Facility
Titan.ium Platform Launches Cloud Native Number Portability Software to Help Telecoms Advance Operational Agility and Network Readiness
RWS and Copyleaks Join Forces to Deliver Built-in AI and Plagiarism Detection for Tridion Users
CRANBURY, N.J., March 10, 2021 (GLOBE NEWSWIRE) — PMV Pharmaceuticals, Inc. (Nasdaq: PMVP), a precision…
~ Presentation to highlight the potential of Gennao’s proprietary, non-viral gene monoclonal antibody (GMAB) platform…
PALO ALTO, Calif., March 10, 2021 (GLOBE NEWSWIRE) — Vincerx Pharma, Inc. (Nasdaq: VINC), a biopharmaceutical…
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, March 10, 2021 (GLOBE NEWSWIRE) — ORIC Pharmaceuticals,…
SOUTH SAN FRANCISCO, Calif., March 10, 2021 (GLOBE NEWSWIRE) — Atreca, Inc. (Atreca) (NASDAQ: BCEL),…
MONTREAL, March 10, 2021 (GLOBE NEWSWIRE) — Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX), a…
CAMBRIDGE, Mass., March 10, 2021 (GLOBE NEWSWIRE) — Rubius Therapeutics, Inc. (Nasdaq:RUBY), a clinical-stage biopharmaceutical…
Tumor model data shows potential of CCR4 antagonist to alter immunosuppressive tumor microenvironment to improve…
RLY-4008 demonstrates strong activity against known clinical on-target resistance mutations in cellular and in vivo…
Additional preclinical data on ZN-c3 and the Company’s EGFR inhibitor, ZN-e4, will be presented as…
FARMINGTON HILLS, Mich., March 10, 2021 (GLOBE NEWSWIRE) — Ocuphire Pharma, Inc. (Nasdaq: OCUP), a…
CAMBRIDGE, Mass., March 10, 2021 (GLOBE NEWSWIRE) — Jounce Therapeutics, Inc. (NASDAQ: JNCE), a clinical-stage…
NEW HAVEN, Conn., March 10, 2021 (GLOBE NEWSWIRE) — Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage…
SAN DIEGO, March 10, 2021 (GLOBE NEWSWIRE) — Histogen Inc. (NASDAQ: HSTO), a clinical-stage therapeutics…
Provided positive update on its four TriTAC® clinical trials, including a confirmed partial response for…
Conference Call and Webcast at 5:00 pm Eastern Time THE WOODLANDS, Texas, March 10, 2021…
– Preparations for potential launch of first Endocrinology Rare Disease product candidate, TransCon hGH (lonapegsomatropin),…
– OASIS Wet AMD Phase 1/2a Trial Initiated and Cohort 1 Dosing Completed – –…
DEINOVE benefits from the support of the French government, within the framework of the “France…
VANCOUVER, British Columbia, March 10, 2021 (GLOBE NEWSWIRE) — Segra International Corp. and Allele Genetics,…